Market revenue in 2023 | USD 101.5 million |
Market revenue in 2030 | USD 170.6 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 71.82% in 2023. Horizon Databook has segmented the South Africa high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Africa is considered the second most populous continent of the world with high incidence o f communicable and noncommunicable diseases. It is estimated that two-thirds o f the yearly mortality is due to noncommunicable diseases such as cancer. Similarly, tuberculosis and HIV/AIDS are identified to be the leading infectious diseases in South Africa.
In addition, incidence of diseases such as cancer is also growing i n the region. For instance, in 2018, according to WHO, 107,467 new cases of cancer were reported i n the region. Technological developments have also enabled the evolution of the pharmaceutical industry in the region.
However, the issue of investment arises when private companies try setting up pharmaceutical production in Africa. This is in contrast to other BRICS nations that are witnessing massive growth in API production. The government of South Africa has made improvements in its basic healthcare by providing free primary healthcare and diagnostic services to children and pregnant ladies.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into South Africa high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account